1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Myoclonus Global Clinical Trials Review, H2, 2014

Myoclonus Global Clinical Trials Review, H2, 2014

  • July 2014
  • -
  • Global Data
  • -
  • 71 pages

Myoclonus Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Myoclonus Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Myoclonus 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Myoclonus 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Myoclonus Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Taro Pharmaceutical Industries Ltd. 28
Clinical Trial Overview of Taro Pharmaceutical Industries Ltd. 28
Clinical Trial Overview of Top Institutes / Government 29
National Pediatric Myoclonus Center 29
Clinical Trial Overview of National Pediatric Myoclonus Center 29
Nanjing Medical University 30
Clinical Trial Overview of Nanjing Medical University 30
First Affiliated Hospital of Henan College 31
Clinical Trial Overview of First Affiliated Hospital of Henan College 31
Foundation IRCCS Neurological Institute Carlo Besta 32
Clinical Trial Overview of Foundation IRCCS Neurological Institute Carlo Besta 32
Hospital Sant Joan de Deu Barcelona 33
Clinical Trial Overview of Hospital Sant Joan de Deu Barcelona 33
National Institute of Neurological Disorders and Stroke 34
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 34
Assistance Publique - Hopitaux de Paris 35
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 35
Academic Medical Center 36
Clinical Trial Overview of Academic Medical Center 36
Mashhad University of Medical Sciences 37
Clinical Trial Overview of Mashhad University of Medical Sciences 37
Institut Curie 38
Clinical Trial Overview of Institut Curie 38
Five Key Clinical Profiles 39
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Myoclonus Therapeutics, Global, Clinical Trials by Region, 2014* 6
Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Myoclonus Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Myoclonus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Myoclonus Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Myoclonus Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Myoclonus Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Myoclonus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Taro Pharmaceutical Industries Ltd., 2014* 28
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Pediatric Myoclonus Center, 2014* 29
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014* 30
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by First Affiliated Hospital of Henan College, 2014* 31
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Foundation IRCCS Neurological Institute Carlo Besta, 2014* 32
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sant Joan de Deu Barcelona, 2014* 33
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 34
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 35
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 36
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014* 37
Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014* 38

List of Figures
Myoclonus Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Myoclonus Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Myoclonus Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.